Patent · US Active

Anti-coagulation factor XI antibodies

US10584179B2 · kind B2 · utility

1Cited by
33References
16Claims
0Family size

Assignees

Inventors

Key dates

Filing dateAug 13, 2018
Grant dateMar 10, 2020
Priority date—
Expiry dateAug 19, 2038

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07K2317/94
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Antibodies that bind the apple 2 domain of human coagulation Factor XI and inhibit activation of FXI by coagulation factor XIIa are described.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.